Second, ApoA-1 and ApoB were not measured at the baseline; however, Ingelsson et al in a large population based study highlighted that the overall performance of ApoB/ApoA-1 for prediction of CHD was comparable with that of traditional lipid ratios, and did not result in incremental utility over TC/HDL-C [37]. This evidence concerns the gene APOA1 and coronary artery disorder.